Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 4 EP applications Jenna Marie Ahern has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14732852

RETOSIBAN FOR THE TREATMENT OF PRE-TERM LABOUR

IPC classification:
A61P 5/24, A61K 31/5377
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16706003

BENZOXABOROLE COMPOUNDS AND USES THEREOF

IPC classification:
A61P 31/06, A61K 31/69, C07F 5/02
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
Request for examination was made
EP16706002

4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/69, A61P 31/06, C07F 5/02
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
Request for examination was made
EP16756795

N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP1, TLL1 AND/OR TLL2 INHIBITORS

IPC classification:
A61P 19/00, A61P 1/16, A61P 13/12, A61P 9/06, A61P 9/04, A61P 9/10, A61K 31/66, A61K 31/341, C07F 9/30, C07D 307/54, C07D 413/12, C07D 407/12, C07D 405/12
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jenna Marie Ahern, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature